Editas Medicine | DEFA14A:其他
04/17 04:31
Editas Medicine | DEF 14A:股东委托书决议
04/17 04:31
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(10.71%),SSGA FUNDS MANAGEMENT, INC.(8.50%)
04/10 21:42
Editas Medicine | 4:持股变动声明-高管 Lucera Erick
03/06 09:09
Editas Medicine | 4:持股变动声明-高管 Burkly Linda
03/06 09:09
Editas Medicine | 4:持股变动声明-高管 O'Neill Gilmore Neil
03/06 09:05
Editas Medicine | 4:持股变动声明-高管 Mei Baisong
03/06 08:59
Editas Medicine | 144:拟议出售证券
03/05 07:02
Editas Medicine | S-3ASR:“知名成熟发行人”证券注册声明
02/29 06:31
Editas Medicine | S-8:员工福利计划证券登记
02/29 05:54
Editas Medicine | 10-K:年度报表
02/29 05:20
Editas Medicine | 8-K:Editas Medicine 公布2023年第四季度和全年业绩和业务更新
02/28 20:07
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%)等
02/14 21:42
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(10.36%)
02/14 07:06
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.6%)
01/25 03:35
Editas Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(6.21%)
01/10 13:00
Editas Medicine | 8-K:重大事件
2023/12/13 22:02
Editas Medicine | 8-K:重大事件
2023/12/12 05:23
Editas Medicine | 4:持股变动声明-高管 Eaton Bruce
2023/12/08 05:30
Editas Medicine | 8-K:重大事件
2023/11/23 05:10
暂无数据
暂无数据